In the last trading session, 1.77 million shares of the Revelation Biosciences Inc (NASDAQ:REVB) were traded, and its beta was 0.24. Most recently the company’s share price was $0.39, and it changed around $0.03 or 7.28% from the last close, which brings the market valuation of the company to $3.28M. REVB currently trades at a discount to its 52-week high of $25.26, offering almost -6376.92% off that amount. The share price’s 52-week low was $0.28, which indicates that the current value has risen by an impressive 28.21% since then. We note from Revelation Biosciences Inc’s average daily trading volume that its 10-day average is 1.11 million shares, with the 3-month average coming to 1.13 million.
Revelation Biosciences Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended REVB as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Instantly REVB has showed a green trend with a performance of 7.28% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4500 on recent trading dayincreased the stock’s daily price by 13.33%. The company’s shares are currently down -97.44% year-to-date, but still up 30.52% over the last five days. On the other hand, Revelation Biosciences Inc (NASDAQ:REVB) is -49.00% down in the 30-day period. We can see from the shorts that 43682.0 shares have been sold at a short interest cover period of 0.03 day(s).
Revelation Biosciences Inc (REVB) estimates and forecasts
Revelation Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -79.41 percent over the past six months and at a 79.76% annual growth rate that is well above the industry average of 16.70%.
REVB Dividends
Revelation Biosciences Inc’s next quarterly earnings report is expected to be released in January.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.06% of Revelation Biosciences Inc shares, and 6.88% of them are in the hands of institutional investors. The stock currently has a share float of 6.89%.
